In an article published in the April issue of Pain Medicine News, counsel Adam Overstreet explains how the DOJ's plan to crack down on and prosecute opioid fraud will impact medical professionals and how they prescribe certain pills. The creation of the Opioid Fraud and Abuse Detection Unit in 2017 seeks to reduce physicians prescribing opioids outside of medical norms and minimize opioid related deaths. "So far, the focus has been on physician practices and so-called pill mills, but the mandate extends to every type of pain management practitioner," he said.

Subscribers may access the full article here.